Client’s Testimonial:
“Thank you so much for all your help during this process. It was great working with you.”
On January 22nd, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Research Scientist in the field of Biomedicine (Approval Notice).
General Field: Biomedicine
Position at the Time of Case Filing: Postdoc
Country of Origin: Iran
State of Residence at the Time of Filing: Ohio
Approval Notice Date: January 22nd, 2025
Processing Time: 7 months, 9 days (Premium Processing Requested)
Case Summary:
A biomedical postdoctoral researcher focusing on therapeutic innovation recently secured approval for an EB-2 National Interest Waiver (NIW), recognizing the national significance of her ongoing efforts to address drug resistance in cancer and infectious diseases. Her research centers on developing combination drug regimens designed to improve treatment efficacy while reducing adverse effects, an endeavor that aligns directly with pressing U.S. public health priorities.
Her academic foundation as an M.D. and her practical research background have enabled her to make meaningful contributions to biomedical science. Her work explores how novel therapeutic strategies can overcome treatment limitations in challenging diseases, ultimately aiming to improve patient outcomes in areas where current options remain insufficient.
She has established a growing scholarly record, with five peer-reviewed publications and one preprint. These works had accrued 87 independent citations at the time of filing—a figure that continued to rise during adjudication—demonstrating sustained field impact. Colleagues in the field have noted the meaningful impact of her research, describing its importance in addressing some of medicine’s most challenging problems. As one expert explained:
“Through her multifaceted approach to research, [Client] has made significant strides in addressing pressing healthcare challenges, such as drug resistance in treating cancer and infectious diseases, positioning herself as a prominent figure in the field of biomedicine.”
Her proposed endeavor is not only scientifically compelling but also nationally important. By advancing therapeutic strategies that can improve treatment response and reduce resistance across major disease categories, her work contributes to efforts that could reduce mortality, lower healthcare burdens, and support long-term public health resilience.
Her successful NIW approval reflects both the value of her contributions and the strength of the documentary evidence prepared and presented by North America Immigration Law Group (NAILG) on her behalf.
Through her continued research, she is positioned to make sustained contributions that advance therapeutic development and improve the nation’s ability to address complex medical challenges, and NAILG is proud to have supported her in achieving this important milestone.
North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).
Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend
With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.
We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours
With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.
Vast Majority of Clients Came to Us Because of Referrals
For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.
Track Record of Success EB-1 and NIW Approvals
Approval Notices: https://www.wegreened.com/eb1_niw_approvals
Success Stories: https://www.wegreened.com/blog/
Website: www.wegreened.com
Free evaluation: https://www.wegreened.com/Free-Evaluation
Tel: 888.666.0969 (Toll Free)
To see more clients’ testimonials and approvals, please refer to:
To Learn More About Your Options CLICK HERE
Copyright © North America Immigration Law Group – WeGreened.com, All Rights Reserved.